Use of inhibitors of the renin-angiotensin system for the treatment of lung injuries

摘要

The invention relates to the use of Angiotensin converting enzyme 2 (ACE2) for the preparation of a medicament for the treatment of severe acute lung injury, especially induced by acid aspiration or sepsis, of lung oedemas and lung injuries and failures connected with infection with severe acute respiratory syndrome (SARS) coronavirus.